Clinerion expanding and moving to new headquarters

Clinerion expanding and moving to new headquarters

Clinerion, which works to accelerate clinical research and medical access to treatments for patients, is expanding its team and moving to new headquarters in Basel, Switzerland. It said that in the six months leading up to the beginning of 2019, it expects to have added several new positions to its global team, and that staffing is increasing in all areas of the company, from customer solutions, site and patient network development, to software development, data analytics and marketing.

The new offices have nearly double the floorspace of its old premises, which matches the increased requirements of Clinerion’s expanding business. The company’s headquarters will remain in Basel as it is a hub for the pharmaceutical industry and home to the headquarters of two of the world’s top-10 pharma companies. “Basel has critical mass in its life sciences ecosystem and an infrastructure which promotes a strong innovation culture,” said Ian Rentsch, Clinerion CEO. “Here, we have the opportunity to interact with leaders of the industry on a close, daily basis. We are happy to be here!”

Pierre Jaccoud, Chairman of the Board of Clinerion, said: “This move offers our employees an improved working environment to support clients and partners more effectively and efficiently, with space for radical, disruptive ideas, and it is in addition a proof of the Board’s trust in the future growth potential.”